Biop Medical is developing a state-of-the-art medical device, capable of monitoring the uterine cervix tissue, using advanced and high-resolution optics. This novel device is intended to assist physicians in diagnosing abnormalities such as lesions or cancer, and selecting areas for biopsy in real time.
Our innovative, low-cost and small sized revolutionary product will provide clear and critical advantages over the current diagnostic technologies.
Our Vision In the future, Biops system will offer electronic medical records (EMR) integration and big data analysis for improved patient treatment and diagnosis. Such digital health capabilities will also allow adoption of Biop's technology in remote locations and clinics, and transfering the scans to larger diagnosis centers.
The systems advanced learning algorithm will continuously enhance its diagnosis capabilities, gleaning from the constantly updated clinical data of different cases. Healthcare providers will receive access to the ever-growing library of scans and outcomes. This big data features will assist physicians in making improved diagnostic decisions. For more information see Future Applications.
Biop Medical won the "best company" award of the first ever IBM start-up accelerator.
Biop Medical is focused on developing next-generation diagnostics for identifying epithelial cancers. We aim to advance the process of screening for cervical cancer to the next level.